Koyfin Home > Directory > Health Care > Abiomed Inc > Cash from Financing Activities

Abiomed Inc Cash from Financing Activities Chart (ABMD)

Abiomed Inc annual/quarterly Cash from Financing Activities from 2010 to 2020.
  • Abiomed Inc Cash from Financing Activities for the quarter ending September 09, 2020 was $5m a 558.04% increase of 30m year over year
  • Abiomed Inc Cash from Financing Activities for the last 12 months ending September 09, 2020 was $-61m a -51.30% increase of 32m year over year
  • Abiomed Inc Annual Cash from Financing Activities for 2020 was $-118m a 52.62% decrease of -62m from 2019
  • Abiomed Inc Annual Cash from Financing Activities for 2019 was $-56m a 83.62% decrease of -47m from 2018
  • Abiomed Inc Annual Cash from Financing Activities for 2018 was $-9m a 142.32% decrease of -13m from 2017
Other Cash Flow Metrics:
  • Abiomed Inc Cash Flow from Operations for the quarter ending September 09, 2018 was $61m a 6.38% increase of 4m year over year
  • Abiomed Inc Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $30m a 50.21% increase of 15m year over year
  • Abiomed Inc Total Revenue for the quarter ending December 12, 2018 was $201m a 13.03% increase of 26m year over year
View Chart On Koyfin

Quarterly ABMD Cash from Financing Activities Data

09/2020$5m
06/2020$-20m
03/2020$-22m
12/2019$-25m
09/2019$-32m
06/2019$-39m
03/2019$3m
12/2018$-1m
09/2018$4m
06/2018$-62m

Annual ABMD Cash from Financing Activities Data

2020$-118m
2019$-56m
2018$-9m
2017$4m
2016$7m
2015$10m
2014$10m
2013$-12m
2012$15m
2011$1m